tiprankstipranks
Bioventus (BVS)
NASDAQ:BVS
US Market
Holding BVS?
Track your performance easily

Bioventus (BVS) Financial Statements

164 Followers

Bioventus Financial Overview

Bioventus's market cap is currently ―. The company's EPS TTM is $-0.617; its P/E ratio is -18.49; Bioventus is scheduled to report earnings on March 20, 2025, and the estimated EPS forecast is $0.08. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 138.96M$ 151.22M$ 129.46M$ 135.42M$ 120.79M
Gross Profit$ 93.55M$ 103.64M$ 88.38M$ 86.30M$ 78.85M
EBIT$ -4.62M$ -39.23M$ -4.85M$ 1.87M$ -7.96M
EBITDA$ 7.66M$ -26.14M$ 6.93M$ 14.34M$ 5.87M
Net Income Common Stockholders$ -4.82M$ -23.99M$ -4.57M$ -6.10M$ -7.30M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 43.07M$ 31.99M$ 25.17M$ 36.96M$ 26.83M
Total Assets$ 769.49M$ 792.17M$ 794.24M$ 810.91M$ 811.10M
Total Debt$ 383.59M$ 383.28M$ 391.24M$ 394.85M$ 394.62M
Net Debt$ 340.51M$ 351.29M$ 366.07M$ 357.88M$ 367.79M
Total Liabilities$ 582.66M$ 603.11M$ 576.81M$ 589.79M$ 584.65M
Stockholders Equity$ 148.74M$ 150.92M$ 171.28M$ 173.59M$ 177.53M
Cash Flow-
Free Cash Flow$ 10.25M$ 15.09M$ -6.30M$ 10.01M$ -10.35M
Operating Cash Flow$ 10.32M$ 15.16M$ -6.00M$ 10.37M$ -8.31M
Investing Cash Flow$ -64.00K$ -77.00K$ -1.00M$ -591.00K$ -2.04M
Financing Cash Flow$ 362.00K$ -7.84M$ -4.24M$ -14.00K$ 8.23M
Currency in USD

Bioventus Earnings and Revenue History

Bioventus Debt to Assets

Bioventus Cash Flow

Bioventus Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis